Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 2, 2012, Pages 196-205

  Reboulleau, Anne ^a   Robert, Véronique ^a,c   Vedie, Benoît ^b   Doublet, Aline ^a   Grynberg, Alain ^a,d   Paul, Jean Louis ^a,b   Fournier, Natalie ^a,b  

^a EA 4529   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UMR1319 MICALIS   (France)

^d UNIVERSITÉ PARIS 13   (France)

Author keywords

ATP binding cassette transporter A1; ATP binding cassette transporter G1; Cardiomyocytes; Cholesterol efflux; Cholesterol homeostasis; Statin

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CHOLESTEROL ESTER; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PRAVASTATIN; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CELL; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOACTIVITY; RAT; UPREGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; CHOLESTEROL, LDL; HOMEOSTASIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCYTES, CARDIAC; PRAVASTATIN; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS NORVEGICUS;

EID: 84862856322     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.05.015     Document Type: Article

References (57)

1. Fuster D., Moe O.W., Hilgemann D.W. Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A 2004, 101:10482-10487.
2. Agarwal S.R., MacDougall D.A., Tyser R., Pugh S.D., Calaghan S.C., Harvey R.D. Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes. J Mol Cell Cardiol 2011, 50:500-509.
3. Paila Y.D., Jindal E., Goswami S.K., Chattopadhyay A. Cholesterol depletion enhances adrenergic signaling in cardiac myocytes. Biochim Biophys Acta 2011, 1808:461-465.
4. Shmeeda H., Petkova D., Barenholz Y. Cholesterol homeostasis in cultures of rat heart myocytes: relationship to cellular hypertrophy. Am J Physiol 1994, 267:H1689-H1697.
5. von Eckardstein A., Nofer J.R., Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001, 21:13-27.
6. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003, 23:712-719.
7. Tall A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008, 263:256-273.
8. van Dam M.J., de Groot E., Clee S.M., Hovingh G.K., Roelants R., Brooks-Wilson A., et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 2002, 359:37-42.
9. Oram J.F., Lawn R.M. ABCA1, the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 2001, 42:1173-1179.
10. Fournier N., Paul J.L., Atger V., Cogny A., Soni T., de la Llera-Moya M., et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997, 17:2685-2691.
11. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004, 101:9774-9779.
12. Mweva S., Paul J.L., Cambillau M., Goudouneche D., Beaune P., Simon A., et al. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur J Clin Invest 2006, 36:552-559.
13. Grynberg A., Athias P., Degois M. Effect of change in growth environment on cultured myocardial cells investigated in a standardized medium. In Vitro Cell Dev Biol 1986, 22:44-50.
14. Leroy C., Tricot S., Lacour B., Grynberg A. Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochim Biophys Acta 2008, 1781:685-693.
15. Athias P., Grynberg A. Electrophysiological studies on heart cells in culture. Heart cell in cultures 1987, 1:125-158. CRC Press, Boca Ranton, Florida. A. Pinson (Ed.).
16. Kritharides L., Jessup W., Mander E.L., Dean R.T. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol 1995, 15:276-289.
17. Terpstra A.H.M., Nicolosi R.J., Herbert P.N. In vitro incorporation of radiolabeled cholesteryl esters into high and low density lipoproteins. J Lipid Res 1989, 30:1663-1671.
18. de la Llera Moya M., Atger V., Paul J.L., Fournier N., Moatti N., Giral P., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994, 14:1056-1065.
19. Attia N., Ramaharo A., Paul J.L., Cambillau M., Beaune P., Grynberg A., et al. Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2008, 198:49-56.
20. Attia N., Fournier N., Vedie B., Cambillau M., Beaune P., Ziegler O., et al. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities. Atherosclerosis 2010, 209:422-429.
21. Smith J.D., Le Goff W., Settle M., Brubaker G., Waelde C., Horwitz A., et al. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res 2004, 45:635-644.
22. Fournier N., Francone O., Rothblat G., Goudouneche D., Cambillau M., Kellner-Weibel G., et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2003, 171:287-293.
23. Fournier N., Atger V., Paul J.L., Sturm M., Duverger N., Rothblat G.H., et al. Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 2000, 20:1283-1292.
24. Saini H.K., Arneja A.S., Dhalla N.S. Role of cholesterol in cardiovascular dysfunction. Can J Cardiol 2004, 20:333-346.
25. Fournier N., Attia N., Rousseau-Ralliard D., Vedie B., Destaillats F., Grynberg A., et al. Deleterious impact of transelaidic fatty acid on ABCA1-mediated cholesterol efflux from mouse and human macrophages. Biochim Biophys Acta 2012, 1821:303-312.
26. Allahverdian S., Pannu P.S., Francis G.A. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res Mar 21 2012, [Epub ahead of print].
27. Connelly M.A., Williams D.L. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol 2004, 15:287-295.
28. Couture L., Nash J.A., Turgeon J. The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacol Rev 2006, 58:244-258.
29. Nishimura M., Naito S., Yokoi T. Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet 2004, 19:135-149.
30. Wellington C.L., Walker E.K., Suarez A., Kwok A., Bissada N., Singaraja R., et al. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 2002, 82:273-283.
31. Koldamova R.P., Lefterov I.M., Ikonomovic M.D., Skoko J., Lefterov P.I., Isanski B.A., et al. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem 2003, 278:13244-13256.
32. Kumar R., McClain D., Young R., Carlson G.A. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells. J Gen Virol 2008, 89:1525-1532.
33. Bortnick A.E., Rothblat G.H., Stoudt G., Hoppe K.L., Royer L.J., McNeish J., et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000, 275:28634-28640.
34. Le Goff W., Peng D.Q., Settle M., Brubaker G., Morton R.E., Smith J.D. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004, 24:2155-2161.
35. Bortnick A.E., Favari E., Tao J.Q., Francone O.L., Reilly M., Zhang Y., et al. Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2003, 285:L869-L878.
36. Choi H.Y., Rahmani M., Wong B.W., Allahverdian S., McManus B.M., Pickering J.G., et al. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009, 119:3223-3231.
37. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000, 275:28240-28245.
38. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 2000, 97:12097-12102.
39. Wang Y., Kurdi-Haidar B., Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 2004, 45:972-980.
40. Slotte J.P., Chait A., Bierman E.L. Cholesterol accumulation in aortic smooth muscle cells exposed to low density lipoproteins. Contribution of free cholesterol transfer. Arteriosclerosis 1988, 8:750-758.
41. Goldstein J.L., Brown M.S. The LDL receptor. Arterioscler Thromb Vasc Biol 2009, 29:431-438.
42. Yokoyama M., Seo T., Park T., Yagyu H., Hu Y., Son N.H., et al. Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle. J Lipid Res 2007, 48:646-655.
43. Larrede S., Quinn C.M., Jessup W., Frisdal E., Olivier M., Hsieh V., et al. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler Thromb Vasc Biol 2009, 29:1930-1936.
44. Zanotti I., Potì F., Favari E., Steffensen K.R., Gustafsson J.A., Bernini F. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP. J Pharmacol Exp Ther 2006, 317:395-401.
45. Llaverias G., Rebollo A., Pou J., Vázquez-Carrera M., Sánchez R.M., Laguna J.C., et al. Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. Biochem Pharmacol 2006, 71:605-614.
46. Jiang Y.J., Lu B., Kim P., Elias P.M., Feingold K.R. Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J Lipid Res 2006, 47:2248-2258.
47. Wong J., Quinn C.M., Gelissen I.C., Jessup W., Brown A.J. The effect of statins onABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation. Atherosclerosis 2008, 196:180-189.
48. Laufs U., Kilter H., Konkol C., Wassmann S., Böhm M., Nickenig G. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 2002, 53:911-920.
49. Mühlhäuser U., Zolk O., Rau T., Münzel F., Wieland T., Eschenhagen T. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. FASEB J 2006, 20:785-787.
50. Porter K.E., Turner N.A., O'Regan D.J., Balmforth A.J., Ball S.G. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc Res 2004, 61:745-755.
51. Oram J.F., Vaughan A.M. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 2000, 11:253-260.
52. Hu Y.W., Ma X., Li X.X., Liu X.H., Xiao J., Mo Z.C., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-e43.
53. Liu Y., Tang C. Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 2012, 1821:522-529.
54. Argmann C.A., Edwards J.Y., Sawyez C.G., O'Neil C.H., Hegele R.A., Pickering J.G., et al. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem 2005, 280:22212-22221.
55. Shand J.H., West D.W. The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. Lipids 1995, 30:917-926.
56. Miura S., Chiba T., Mochizuki N., Nagura H., Nemoto K., Tomita I., et al. Cholesterol-mediated changes of neutral cholesterol esterase activity in macrophages. Mechanism for mobilization of cholesteryl esters in lipid droplets by HDL. Arterioscler Thromb Vasc Biol 1997, 17:3033-3040.
57. Isusi E., Aspichueta P., Liza M., Hernández M.L., Díaz C., Hernández G., et al. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes. Atherosclerosis 2000, 153:283-294.